Economic burden of epilepsy among the privately insured in the US

PharmacoEconomics

Volumn 28, Issue 8, 2010, Pages 675-685

  Ivanova, Jasmina I ^a   Birnbaum, Howard G ^a   Kidolezi, Yohanne ^a   Qiu, Ying ^a   Mallett, David ^b   Caleo, Sue ^c  

^a ANALYSIS GROUP   (United States)

^b Ingenix Employer Solutions   (United States)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Cost of illness; Epilepsy, treatment.

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; EMPLOYEE; EPILEPSY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE;

ADOLESCENT; ADULT; COST OF ILLNESS; DRUG COSTS; EPILEPSY; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; PRIVATE SECTOR; RISK ADJUSTMENT; UNITED STATES; YOUNG ADULT;

EID: 77954519048     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11535570-000000000-00000     Document Type: Article

References (26)

1. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in theUnited States: an estimate frompopulation-based clinical and survey data. Epilepsia 2000 Mar; 41 (3): 342-351
2. Halpern M, RentzA, MurrayM. Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates. Neuroepidemiology 2000 Mar-Apr; 19 (2): 87-99
3. World Health Organization. Epilepsy: aetiogy, epidemiology and prognosis [online]. Available from URL: http:// www.who.int/mediacentre/factsheets/fs165/ en/ [Accessed 2008 Apr 29]
4. Engel Jr J, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Neurology 2003; 60: 538-547 [online]. Available from URL: http://www.neurology.org/cgi/reprint/60/4/538.pdf [Accessed 2010 Feb 3]
5. 1987 NMES household survey and health insurance plans survey data [CD-ROM; AHCPR Pub. No. 98-DP02]. Rockville (MD): Agency for Health Care Policy and Research, 1987
6. Strzelczyk A, Reese JP, Dodel R, et al. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008; 26 (6): 463-476
7. Murray MI,Halpern MT, Lepik IE. Cost of refractory epilepsy in adults in the USA. Epilepsy Res 1996 Mar; 23 (2): 139-148
8. van Hout B, Gagnon D, Souetre E, et al. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia 1997 Nov; 38 (11): 1221-1226
9. Jacoby A, Buck D, Baker G, et al. Uptake and costs of care for epilepsy: findings from a UK regional study. Epilepsia 1998 July; 39 (7): 776-786
10. Berto P, Tinuper P, Viaggi S. Cost-of-illness of epilepsy in Italy: data from a multicentre observational study (Episcreen). Pharmacoeconomics 2000 Feb; 17 (2): 197-208
11. Hamer HM, Spottke A, Aletsee C, et al. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany. Epilepsia 2006 Dec; 47 (12): 2165-2172
12. Health Affairs. Number of Americans with job-based health benefits grew through early 2001, despite higher benefit costs. 2002 Jan 8 [press release; online]. Available from URL: http://www.healthaffairs.org/press/janfeb0202.htm [Accessed 2002 Jun 17]
13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (5): 373-383
14. Romano PS, Roos LL, Jollis J. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1993; 46 (10): 1075-1079
15. Ivanova JI, Birnbaum HG, Samuels S, et al. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US. Pharmacoeconomics 2009; 27 (8): 681-691
16. White AG, Birnbaum HG, Janagap C, et al. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States. J Occup Environ Med 2008 Sep; 50 (9): 998-1005
17. Lee LJ, Yu AP, Cahill KE, et al. Direct and indirect costs among employees with diabetic retinopathy in the United States. Curr Med Res Opin 2008 May; 24 (5): 1549-1559
18. Begley CE, Lairson DR, Reynolds TF, et al. Early treatment cost in epilepsy and how it varies with seizure type and frequency. Epilepsy Res 2001 Dec; 47 (3): 205-215
19. Cockerell OC, Hart YM, Sander JW, et al. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res 1994 Jul; 18 (3): 249-260
20. De Zélicourt M, Buteau L, Fagnani F, et al. The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study). Active Coordination of the Longitudinal Observational Network in Epilepsy. Seizure 2000 Mar; 9 (2): 88-95
21. Haerer AF, Anderson DW, Schoenberg BS. Prevalence and clinical features of epilepsy in a biracial United States population. Epilepsia 1986; 27: 66-75
22. Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975; 16: 1-66
23. Adams PF, Benson V. Current estimates from the National Health interview survey, 1989. Vital Health Stat 10 1990 Oct; (176): 1-221
24. Begley CE, Annegers JF, Lairson DL, et al. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994 Nov-Dec; 35 (6): 1230-1243
25. US Bureau of the Census. Current population surveys, March 1996. Washington, DC: Bureau of the Census, 1996
26. Hofferth S, Stafford FP, Yeung WJ, et al. Panel study of income dynamics, 1968-1992. Ann Arbor (MI): Survey Research Center, 1995